Description and Brand Names
Drug information provided by: IBM Micromedex
Belantamab mafodotin-blmf injection is used to treat multiple myeloma (a type of bone marrow cancer) in patients whose cancer has come back and who have received at least 4 previous treatments (eg, anti-CD38 monoclonal antibody, a proteasome inhibitor, and an immunomodulatory agent) that did not work well.
This medicine is available only under a restricted distribution program called the Blenrep REMS (Risk Evaluation and Mitigation Strategy) program.
This product is available in the following dosage forms: